Respiratory syncytial virus infection
RecruitingStudy of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection
Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection
- Disease:Respiratory syncytial virus infection
- Substances:GSKVx000000017064
Sweden- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:GSKVx000000017064
- Sponsor:Karolinska Institutet



